---
title: "Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.76, Implies 13% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293677051.md"
description: "Analysts have raised the 12-month average price target for Teladoc Health, Inc. to $7.76 from $7.55, based on estimates from 19 analysts. Despite this increase, the new target implies a 13% downside from the July 22 closing price. The consensus rating remains 'Hold' among 25 covering analysts, comprising 5 Buys, 19 Holds, and 1 Sell."
datetime: "2026-07-23T23:20:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293677051.md)
  - [en](https://longbridge.com/en/news/293677051.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293677051.md)
generator: "portal-rs"
---

# Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.76, Implies 13% Downside

-   According to estimates from 19 analysts, Teladoc Health, Inc. stock's average price target has risen from $7.55 to $7.76, with forecasts ranging from $5 to $11 per share
-   Based on the Jul. 22 closing price, the updated target implies approximately 13% potential downside
-   Consensus rating remains at “Hold” across 25 covering analysts, with 5 Buys, 19 Holds and 1 Sells

Explore more price target data and ratings for Teladoc Health, Inc. on the , and track all previous and future analyst recommendations for Teladoc Health, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Empowered Funds LLC Invests $5.76 Million in Teladoc Health, Inc. $TDOC](https://longbridge.com/en/news/297483011.md)
- [Moore Capital Management LP Sells 379,128 Shares of Teladoc Health, Inc. $TDOC](https://longbridge.com/en/news/297761831.md)
- [Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment](https://longbridge.com/en/news/297585950.md)
- [Teladoc BetterHelp President Fernando M. Rodrigues sells TDOC shares worth $98,912.16](https://longbridge.com/en/news/297952904.md)
- [Teladoc files Form 3 for CFO Michael F. Grasher](https://longbridge.com/en/news/297700235.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**